SCM
ATRC icon

Semanteon Capital Management’s AtriCure ATRC Stock Holding History

Semanteon Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,001
Closed -$564K – 27
2025
Q3 		$564K Buy
+16,001
New +$551K 0.71% 69
2024
Q1 		– Sell
-32,305
Closed -$1.15M – 221
2023
Q4 		$1.15M Buy
+32,305
New +$1.2M 0.78% 50

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Semanteon Capital Management's ATRC Position: Q4 2025 in Review

Semanteon Capital Management sold out of AtriCure (ATRC) in Q4 2025, closing a stake of 16,001 shares — an estimated $564K sold.

Semanteon Capital Management first reported a position in ATRC in Q4 2023 and held it in 2 quarters. The position peaked at $1.15M in Q4 2023. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2025.

  • Semanteon Capital Management reported no remaining AtriCure position as of Q4 2025 after selling out during the quarter.
  • Semanteon Capital Management sold 16,001 AtriCure shares in Q4 2025, an estimated $564K.
  • Semanteon Capital Management first reported a position in AtriCure in Q4 2023 and held it in 2 quarters.
  • Semanteon Capital Management's AtriCure position peaked at $1.15M in Q4 2023.
  • 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2025.

Based on Semanteon Capital Management's 13F filing for Q4 2025, filed 10 Feb 2026.